This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Dextenza (Ocular Therapeutix Inc.) for the treatment of ocular pain and inflammation after refractive surgery in adults.
If you have a Hayes login, click here to view the full report on the Knowledge Center.